期刊
FRONTIERS IN IMMUNOLOGY
卷 4, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2013.00422
关键词
CD57; NK cells; HCMV infection; ageing; chronic infection; cancer; autoimmune diseases; T cells
类别
资金
- UK Medical Research Council [G1000808]
- MRC [MR/J003999/1]
- MRC [G0400225, G1000808] Funding Source: UKRI
- Medical Research Council [1264001, G0400225, G1000808] Funding Source: researchfish
Historically, human NK cells have been identified as CD3(-)CD56(+)CD16(+/-) lymphocytes. More recently it has been established that CD57 expression defines functionally discrete sub-populations of NK cells. On T cells, CD57 expression has been regarded as a marker of terminal differentiation and (perhaps wrongly) of anergy and senescence. Similarly, CD57 expression seems to identify the final stages of peripheral NK cell maturation; its expression increases with age and is associated with chronic infections, particularly human cytomegalovirus infection. However, CD57(+) NK cells are highly cytotoxic and their presence seems to be beneficial in a number of non-communicable diseases. The purpose of this article is to review our current understanding of CD57 expression as a marker of NK cell function and disease prognosis, as well as to outline areas for further research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据